Weihua Zhang

机构：Peking University, Dalian University of Technology, Zhongda Hospital Southeast University, Xian Yang Central Hospital, Peking University Sixth Hospital · ORCID：0000-0003-0662-7018

发表论文 38 篇 · 总被引 389 次 · h-index 11

代表论文

• Safety and efficacy of lenvatinib combined with camrelizumab plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A two-center retrospective study (2022 · Frontiers in Oncology · 被引 41)
• Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma (2022 · BMC Cancer · 被引 40)
• Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives (2024 · United European Gastroenterology Journal · 被引 19)
• Longitudinal Body Composition Identifies Hepatocellular Carcinoma With Cachexia Following Combined Immunotherapy and Target Therapy (CHANCE2213) (2024 · Journal of Cachexia Sarcopenia and Muscle · 被引 15)
• Brain Gray Matter Alterations in Hepatic Encephalopathy: A Voxel-Based Meta-Analysis of Whole-Brain Studies (2022 · Frontiers in Human Neuroscience · 被引 15)
• The Effect of Alcohol Consumption in Unresectable Hepatocellular Carcinoma with Transarterial Chemoembolization (2022 · Journal of Oncology · 被引 14)